 RADNOR, Pa., Feb. 23, 2021 PRNewswire -- NeuroRx, Inc. announced today that the Phase 2b3 trial of ZYESAMITM aviptadil, previously RLF-100TM for the treatment of Respiratory Failure in critically ill patients with Covid-19 has demonstrated multidimensional benefit around its... 